Two Sigma Investments — REGN Trade History
Quarter-by-quarter changes in the REGENERON PHARMACEUTICALS position · CUSIP 75886F107
Currently held · 2 YearsFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 656,124 | -156,112 | -19.2% | $409.1M | 0.30% |
| 2026 Q1 | 2026-05-15 | Add | 812,236 | 531,085 | +188.9% | $627.6M | 0.51% |
| 2025 Q4 | 2026-02-17 | Reduce | 281,151 | -188,752 | -40.2% | $217.0M | 0.31% |
| 2025 Q3 | 2025-11-14 | Reduce | 469,903 | -29,925 | -6.0% | $264.2M | 0.39% |
| 2025 Q2 | 2025-08-14 | Add | 499,828 | 127,757 | +34.3% | $262.4M | 0.47% |
| 2025 Q1 | 2025-05-15 | Add | 372,071 | 337,528 | +977.1% | $236.0M | 0.50% |
| 2024 Q4 | 2025-02-14 | Add | 34,543 | 12,154 | +54.3% | $24.6M | 0.05% |
| 2024 Q3 | 2024-11-14 | New | 22,389 | 22,389 | — | $23.5M | 0.05% |
| 2024 Q2 | 2024-08-14 | Sold out | — | -4,781 | -100.0% | — | — |
| 2024 Q1 | 2024-05-15 | Reduce | 4,781 | -60,437 | -92.7% | $4.6M | 0.01% |
| 2023 Q4 | 2024-02-14 | Reduce | 65,218 | -23,497 | -26.5% | $57.3M | 0.13% |
| 2023 Q3 | 2023-11-14 | Reduce | 88,715 | -34,911 | -28.2% | $73.0M | 0.20% |
| 2023 Q2 | 2023-08-14 | Reduce | 123,626 | -65,669 | -34.7% | $88.8M | 0.22% |
| 2023 Q1 | 2023-05-15 | Add | 189,295 | 157,137 | +488.6% | $155.5M | 0.45% |
| 2022 Q4 | 2023-02-14 | New | 32,158 | 32,158 | — | $23.2M | 0.07% |
| 2022 Q3 | 2022-11-14 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-15 | Sold out | — | -207,430 | -100.0% | — | — |
| 2022 Q1 | 2022-05-16 | Reduce | 207,430 | -115,987 | -35.9% | $144.9M | 0.43% |
| 2021 Q4 | 2022-02-14 | Add | 323,417 | 318,349 | +6281.6% | $204.2M | 0.44% |
| 2021 Q3 | 2021-11-15 | New | 5,068 | 5,068 | — | $3.1M | 0.01% |
| 2021 Q2 | 2021-08-16 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-17 | Sold out | — | -6,492 | -100.0% | — | — |
| 2020 Q4 | 2021-02-16 | New | 6,492 | 6,492 | — | $3.1M | 0.01% |
| 2020 Q3 | 2020-11-16 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-14 | Sold out | — | -51,959 | -100.0% | — | — |
| 2020 Q1 | 2020-05-15 | New | 51,959 | 51,959 | — | $25.4M | 0.21% |
| 2019 Q4 | 2020-02-14 | Sold out | — | -127,116 | -100.0% | — | — |
| 2019 Q3 | 2019-11-14 | New | 127,116 | 127,116 | — | $35.3M | 0.12% |
| 2019 Q2 | 2019-08-14 | Sold out | — | -23,316 | -100.0% | — | — |
| 2019 Q1 | 2019-05-15 | Reduce | 23,316 | -12,182 | -34.3% | $9.6M | 0.03% |
| 2018 Q4 | 2019-02-14 | Reduce | 35,498 | -75,574 | -68.0% | $13.3M | 0.05% |
| 2018 Q3 | 2018-11-14 | Reduce | 111,072 | -372,262 | -77.0% | $44.9M | 0.12% |
| 2018 Q2 | 2018-08-14 | Add | 483,334 | 27,415 | +6.0% | $166.7M | 0.50% |
| 2018 Q1 | 2018-05-15 | Add | 455,919 | 112,147 | +32.6% | $157.0M | 0.52% |
| 2017 Q4 | 2018-02-14 | New | 343,772 | 343,772 | — | $129.2M | 0.42% |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | Sold out | — | -34,212 | -100.0% | — | — |
| 2017 Q1 | 2017-05-15 | Reduce | 34,212 | -34,394 | -50.1% | $13.3M | 0.04% |
| 2016 Q4 | 2017-02-14 | Add | 68,606 | 65,031 | +1819.0% | $25.2M | 0.10% |
| 2016 Q3 | 2016-11-14 | New | 3,575 | 3,575 | — | $1.4M | 0.01% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.